Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Carolien H Smorenburg"'
Autor:
Vivianne C.G. Tjan-Heijnen, Senna W.M. Lammers, Sandra M.E. Geurts, Ingeborg J.H. Vriens, Astrid C.P. Swinkels, Carolien H. Smorenburg, Maurice J.C. van der Sangen, Judith R. Kroep, Hiltje de Graaf, Aafke H. Honkoop, Frans L.G. Erdkamp, Wilfred K. de Roos, Sabine C. Linn, Alexander L.T. Imholz
Publikováno v:
EClinicalMedicine, Vol 58, Iss , Pp 101901- (2023)
Summary: Background: The DATA study evaluated the use of two different durations of anastrozole in patients with hormone receptor-positive breast cancer who were disease-free after 2–3 years of tamoxifen. We hereby present the follow-up analysis, w
Externí odkaz:
https://doaj.org/article/5623c66d14bc4b84bad476914391d5ba
Autor:
Nathalie I. Bouwer, Tessa G. Steenbruggen, Hánah N. Rier, Jos J. E. M. Kitzen, Carolien H. Smorenburg, Marlies L. van Bekkum, Paul C. de Jong, Jan C. Drooger, Cynthia Holterhues, Marcel J. M. Kofflard, Eric Boersma, Gabe S. Sonke, Mark‐David Levin, Agnes Jager
Publikováno v:
International Journal of Cancer, 151(4), 616-622. Wiley-Liss Inc.
We investigated the effect of trastuzumab on cardiac function in a real-world historic cohort of patients with HER2-positive metastatic breast cancer (MBC) with reduced baseline left ventricular ejection fraction (LVEF). Thirty-seven patients with HE
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 166
Breast cancer is the most commonly occurring malignancy in women. Every year, this type of cancer is newly diagnosed in almost 15,000 women and over 100 men in the Netherlands. The prognosis of breast cancer has improved considerably due to timely re
Autor:
Carolien H. Smorenburg, Agnes Jager, Cynthia Holterhues, Tessa G Steenbruggen, Mark-David Levin, Marcel J.M. Kofflard, Hánah N. Rier, Eric Boersma, Gabe S. Sonke, Jan C. Drooger, Jos J. E. M. Kitzen, Paul de Jong, Marlies L. van Bekkum, Albert J. ten Tije, Nathalie I. Bouwer
Publikováno v:
Cancer Research. 81:PS13-21
Research objectives and rationale Trastuzumab greatly enhances the efficacy of treatment in HER2+ metastatic breast cancer (MBC). Due to its potential to induce cardiomyopathy, however, trastuzumab is contraindicated in patients with baseline left ve
Autor:
Gabe S. Sonke, Carolien H. Smorenburg, Hánah N. Rier, M-D. Levin, Tessa G Steenbruggen, Agnes Jager, Jos J. E. M. Kitzen, J. van Rosmalen, Jan C. Drooger, Nathalie I. Bouwer, Eric Boersma, A. J. Ten Tije, C Holterhues, P. C. De Jong, M. L. van Bekkum, Marcel J.M. Kofflard
Publikováno v:
Breast Cancer Research and Treatment, 186(3), 851-862. Springer New York
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment
Purpose Patients with HER2-positive metastatic breast cancer (MBC) usually receive many years of trastuzumab treatment. It is unknown whether these patients require continuous left ventricular ejection fraction (LVEF) monitoring. We studied a real-wo
Autor:
Rieneke T Lugtenberg, Corina JG van den Hurk, Carolien H Smorenburg, Linda Mosch, Danny Houtsma, Margaret AG den Hollander - van Deursen, Ad A Kaptein, Hans Gelderblom, Judith R Kroep
Purpose Scalp cooling can prevent chemotherapy-induced alopecia (CIA). Previously, the post-infusion cooling time (PICT) could be successfully reduced in docetaxel-treated patients from 90 to 45 and 20 minutes. Therefore it seems plausible that the P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ef80b333690f602b1604af980bb5def
https://doi.org/10.21203/rs.3.rs-1419288/v1
https://doi.org/10.21203/rs.3.rs-1419288/v1
Autor:
Rieneke T, Lugtenberg, Corina J G, van den Hurk, Carolien H, Smorenburg, Linda, Mosch, Danny, Houtsma, Margaret A G den Hollander-van, Deursen, Ad A, Kaptein, Hans, Gelderblom, Judith R, Kroep
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 30(8)
Scalp cooling can prevent chemotherapy-induced alopecia (CIA). Previously, the post-infusion cooling time (PICT) could be successfully reduced in docetaxel-treated patients from 90 to 45 and 20 min. Therefore, it seems plausible that the PICT can be
Autor:
M. A. Hillen, Carolien H. Smorenburg, E. Heeg, Y. A. Civil, Leonie A. E. Woerdeman, Emma J. Groen, M.T.F.D. Vrancken Peeters, H.A.O. Winter-Warnars
Publikováno v:
Annals of Surgical Oncology
Annals of surgical oncology, 26(13), 4355-4363. Springer New York
Annals of surgical oncology, 26(13), 4355-4363. Springer New York
Background Breast cancer care is becoming increasingly complex, and patients with breast cancer are increasingly aware of the different treatment options, resulting in requests for second opinions (SOs). The current study investigates the impact of b
Autor:
WK de Roos, Frans L. G. Erdkamp, H de Graaf, IE van Hellemond, M. de Boer, M. van der Sangen, Carolien H. Smorenburg, Aafke H. Honkoop, F.W.P.J. van den Berkmortel, Carine Seynaeve, VC Tjan-Heijnen, Astrid C P Swinkels, Pgm Peer, A.L.T. Imholz, Judith R. Kroep, Sabine C. Linn
Publikováno v:
Cancer Research. 79:P4-14
Background: The phase III DATA study (NCT00301457) investigates the efficacy of 6 versus 3 years of adjuvant anastrozole after an initial 2-3 year treatment with tamoxifen in postmenopausal women with breast cancer. A reduced bone mineral density (BM
Autor:
P. C. De Jong, Joyce Sanders, Nathalie I. Bouwer, A. J. Ten Tije, Karin Beelen, Hugo M. Horlings, Hánah N. Rier, Carolien H. Smorenburg, GS Sonke, M-D Levin, C Holterhues, Jan C. Drooger, Agnes Jager, Tessa G Steenbruggen
Publikováno v:
Cancer Research. 79:P6-17
Intro MBC is generally considered incurable, but patients with HER2+ disease treated with trastuzumab do relatively well and some have an exceptional durable response and survive over 10 years. We analyzed the clinical-pathological characteristics as